Semax: Semax (natively labeled Семакс) is a Russian pharmaceutical neuropeptide developed in the 1980s and approved for clinical use in 1996 after a 14-year-long testing period. While commonly prescribed in Russia, Ukraine, and other CIS nations for a wide range of conditions including stroke/ischem
Related pages